title: Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients.
authors.forename: R
authors.initials: R
authors.lastname: Husak
authors.forename: C C
authors.initials: CC
authors.lastname: Zouboulis
authors.forename: C
authors.initials: C
authors.lastname: Sander-Bähr
authors.forename: M
authors.initials: M
authors.lastname: Hummel
authors.forename: C E
authors.initials: CE
authors.lastname: Orfanos
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D063065:Organophosphonates / Q000627:therapeutic use*; D027383:Papillomaviridae; D014860:Warts / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir